Summary BG Medicine, Inc. (BGM) formerly Beyond Genomics, Inc. is a medical device company that discovers, develops and delivers diagnostic solutions. The company offers diagnostics to aid in the clinical management of heart failure and related disorders. It offers test products which includes BGM Galectin-3. BGM's BGM Galectin-3 is a diagnostic test, which measures galectin-3 levels in blood plasma or serum. The company's BGM Galectin-3 test is available in Europe as an aid in assessing the prognosis of patients diagnosed with acute and chronic heart failure. It caters its products to healthcare providers. BGM is headquartered in Waltham, Massachusetts, the US. This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. Scope: - The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments - The report analyzes all pipeline products in development for the company BG Medicine, Inc. - The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status) - The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date - The report provides detailed description of products in development, technical specification and functions - The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date. Reasons To Buy: - Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape - Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio - To formulate effective Research & Development strategies - Develop market-entry and market expansion strategies - Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return - Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc - Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
Table of Contents 2 List of Tables 4 List of Figures 5 BG Medicine, Inc. Company Snapshot 6 BG Medicine, Inc. Company Overview 6 BG Medicine, Inc. Pipeline Products and Clinical Trials Overview 7 BG Medicine, Inc.- Pipeline Analysis Overview 9 Key Facts 9 BG Medicine, Inc. - Major Products and Services 10 BG Medicine, Inc. Pipeline Products by Development Stage 11 BG Medicine, Inc. Pipeline Products Overview 13 BGM Galectin-3 Test - Adverse Cardiovascular Events 13 BGM Galectin-3 Test - Adverse Cardiovascular Events Product Overview 13 Biomarkers - Enbrel Treatment 14 Biomarkers - Enbrel Treatment Product Overview 14 Biomarkers - Humira Treatment 15 Biomarkers - Humira Treatment Product Overview 15 Biomarkers - Remicade Treatment 16 Biomarkers - Remicade Treatment Product Overview 16 Diagnostic Assay - Multiple Sclerosis 17 Diagnostic Assay - Multiple Sclerosis Product Overview 17 LipidDx 18 LipidDx Product Overview 18 Molecular Diagnostic Test For Avandia Treatment 19 Molecular Diagnostic Test For Avandia Treatment Product Overview 19 BG Medicine, Inc. - Key Competitors 20 BG Medicine, Inc. - Key Employees 21 BG Medicine, Inc. - Locations And Subsidiaries 22 Head Office 22 Recent Developments 23 BG Medicine, Inc., Recent Developments 23 Dec 23, 2015: BG Medicine Withdraws 510(k) Premarket Notification for Proposed Additional Indication for the BGM Galectin-3 Test 23 Nov 17, 2015: BG Medicine Reports Third Quarter 2015 Financial Results 23 Sep 15, 2015: BG Medicine to Begin Trading on the OTCQB 24 Aug 14, 2015: BG Medicine Reports Second Quarter 2015 Financial Results 24 May 14, 2015: BG Medicine Reports First Quarter 2015 Financial Results 25 Mar 31, 2015: BG Medicine Reports 2014 Fourth Quarter and Year End Financial Results 26 Mar 31, 2015: BG Medicine Submits 510(k) to FDA for Additional Indication for the BGM Galectin-3 Test 26 Mar 26, 2015: BG Medicine Welcomes Major Publication on the BioImage Study in the Journal of the American College of Cardiology 27 Feb 02, 2015: BG Medicine Announces Receipt of Favorable NASDAQ Listing Determination 27 Nov 20, 2014: BG Medicine, Welcomes Presentation of Clinical Data on Galectin-3 Testing at the American Heart Association 2014 Scientific Sessions Conference 28 Appendix 30 Methodology 30 About GlobalData 30 Contact Us 30 Disclaimer 30
List of Tables
BG Medicine, Inc. Pipeline Products and Clinical Trials Overview 7 BG Medicine, Inc. Pipeline Products by Equipment Type 7 BG Medicine, Inc. Pipeline Products by Indication 8 BG Medicine, Inc., Key Facts 9 BG Medicine, Inc., Major Products and Services 10 BG Medicine, Inc. Number of Pipeline Products by Development Stage 11 BG Medicine, Inc. Pipeline Products Summary by Development Stage 12 BGM Galectin-3 Test - Adverse Cardiovascular Events - Product Status 13 BGM Galectin-3 Test - Adverse Cardiovascular Events - Product Description 13 Biomarkers - Enbrel Treatment - Product Status 14 Biomarkers - Enbrel Treatment - Product Description 14 Biomarkers - Humira Treatment - Product Status 15 Biomarkers - Humira Treatment - Product Description 15 Biomarkers - Remicade Treatment - Product Status 16 Biomarkers - Remicade Treatment - Product Description 16 Diagnostic Assay - Multiple Sclerosis - Product Status 17 Diagnostic Assay - Multiple Sclerosis - Product Description 17 LipidDx - Product Status 18 LipidDx - Product Description 18 Molecular Diagnostic Test For Avandia Treatment - Product Status 19 Molecular Diagnostic Test For Avandia Treatment - Product Description 19 BG Medicine, Inc., Key Employees 21
List of Figures
BG Medicine, Inc. Pipeline Products by Equipment Type 8 BG Medicine, Inc. Pipeline Products by Development Stage 11
Global fingerprint access control systems market size is estimated to reach USD 4.4 billion by 2022, as per a new research report by Radiant Insights, Inc. Growing safety and security concerns of individual as well as organization is projected to driRead More...
Global animal feed additives market size was estimated at USD 16 billion in 2014. Growing meat consumption as a key protein source, especially in Asia Pacific and Latin America is expected to be a key driver for market demand over the forecast periodRead More...
Global alpha olefins market size is likely to be valued at USD 10.7 billion by 2020; as per a new research report by Radiant Insights, Inc. Increasing polyethylene demand for use in plastic production is anticipated to drive market growth. Growing apRead More...
Global commercial drone market size is estimated to reach USD 2,069.6 million by 2022, as per a new research report by Radiant Insights, Inc. Increasing application of these machines in various industry sectors such as military, agriculture and energRead More...
Global aerospace plastics market size is likely to be valued at USD 13.48 billion by 2020; as per a new research report by Radiant Insights, Inc. Growing application scope of lightweight materials in aerospace industry is likely to drive market growtRead More...
Get your queries resolved from an industry expert. Request for a free product review before report purchase.
Toll Free: 1-888-928-9744
Email: [email protected]
Speak to the report author to design an exclusive study to serve your research needs.
A testimonial for service excellence represented in the form of BBB "A" Accreditation.
Your personal and confidential information is safe and secure.